Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SSI-PADS: Postoperative Cefaclor vs No Antibiotics in Dermatologic Surgery
jRCT1031220718Recruiting
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of cefaclor (2 arms). Primary endpoint: Incidence of surgical site infection at 7 days after surgery. Started Jul 2024; status: recruiting.
02
Drugs
cefaclor
Beyond the preview
Go deeper on jRCT1031220718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031220718.